Eculizumab in Transplant-Associated Thrombotic Microangiopathy. - Wikidata - awgldk - TriplyDB

Eculizumab in Transplant-Associated Thrombotic Microangiopathy.

Eculizumab in Transplant-Associated Thrombotic Microangiopathy.

http://www.wikidata.org/entity/Q33425079

about

Hematopoietic cell transplantation-associated thrombotic microangiopathy: a review of pathophysiology, diagnosis, and treatment Two cases of kidney transplantation-associated thrombotic microangiopathy successfully treated with eculizumab.New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy.HUS and atypical HUS.Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies.Impact of treatment and outcomes for patients with posttransplant drug-associated thrombotic microangiopathy.A case of atypical hemolytic uremic syndrome in a second renal transplant.

P2860

Q28069228-1B0B8BE5-943F-45DD-AE9B-EDAD23F3B747 Q33430681-EBFF1814-2D05-4035-B405-0D31207BA60A Q33432069-F234ACBD-62E9-488F-BE17-B8C1DC354CAE Q33441069-2618416B-BA7D-49F9-B321-DAAF342C31D3 Q41992358-CDCF1E97-F027-409D-9AD3-B293E715392D Q47912606-55ECA5ED-AF0D-4476-B350-4D4472A6994F Q48209875-3EEE5423-A954-489F-B647-025FC3FBF6F0

P2860

Eculizumab in Transplant-Associated Thrombotic Microangiopathy.

http://www.wikidata.org/entity/Q33425079

description

2015 nî lūn-bûn

@nan

2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Eculizumab in Transplant-Associated Thrombotic Microangiopathy.

@ast

Eculizumab in Transplant-Associated Thrombotic Microangiopathy.

@en

type

label

Eculizumab in Transplant-Associated Thrombotic Microangiopathy.

@ast

Eculizumab in Transplant-Associated Thrombotic Microangiopathy.

@en

prefLabel

Eculizumab in Transplant-Associated Thrombotic Microangiopathy.

@ast

Eculizumab in Transplant-Associated Thrombotic Microangiopathy.

@en

P1433

Q33425079-FED8EBBB-77EC-4300-B05B-A6A5525BFC18

P1476

Q33425079-8B0EC663-45F4-40C1-85F1-26652484E758

P2093

Q33425079-015D649B-059F-4999-A5DD-CAC0FE7974A4

Q33425079-3D9CAA0E-5865-4352-997B-8BBD98A28862

Q33425079-E7C4F67D-2273-440F-A2B6-14D1DE73EA37

P2860

Q33425079-11ECDE2D-28BE-46C5-99F0-28D502790264

Q33425079-29B0D7E1-9B9F-459B-AB2C-E671C8FB9E90

Q33425079-2AC0E051-1A0C-4091-9BE1-E55C680E2E9D

Q33425079-41FA0B97-BD06-46A7-8835-A4311AD8414B

Q33425079-4284AF87-6637-4A43-BF99-00F1D7E17DFB

Q33425079-48AB255F-B922-4101-AA0D-BEA4EAC2BE03

Q33425079-4BB34617-2349-4F81-8DA1-290E80EE5B71

Q33425079-53C97E6E-34AE-4B3C-A809-130BDB3EAF2B

Q33425079-54FD36F5-FB2C-4FE8-9C55-D70C7C43C776

Q33425079-5B5132C3-7E43-43B3-8778-1679E62BAB90

P304

Q33425079-EDDA6A88-253A-4B14-A968-9952DF674EEA

P31

Q33425079-CD7A3AE2-E6B1-4937-8DD6-975EA8B3DB57

Q33425079-e00b1919-9be9-43b5-80b3-e028cda4080a

P356

Q33425079-71169CED-8714-4B55-9609-57569FE96583

P433

Q33425079-2B586A5E-D770-4063-BF59-03AE872D87A1

P478

Q33425079-E3E55FA8-A650-40AD-A38D-CF037AF97232

P50

Q33425079-7B2A379A-0F7C-4E7A-9E22-29DFB0541DF0

P577

Q33425079-F3642835-0A48-4905-8848-C1BE123BCF64

P698

Q33425079-9D45777C-7A06-43D7-B8AC-B4014C2AD62E

P356

1076029615599439

P1433

Clinical and Applied Thrombosis-Hemostasis

P1476

Eculizumab in Transplant-Associated Thrombotic Microangiopathy

@en

P2093

Prajwal Dhakal

http://www.w3.org/2001/XMLSchema#string

Ranjan Pathak

http://www.w3.org/2001/XMLSchema#string

Smith Giri

http://www.w3.org/2001/XMLSchema#string

P2860

Pros and cons for C4d as a biomarker.

Transplantation-associated thrombotic microangiopathy is associated with transplantation from unrelated donors, acute graft-versus-host disease and venoocclusive disease of the liver.

Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma.

Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation.

Transplant-associated microangiopathy (TAM) in recipients of allogeneic hematopoietic stem cell transplants.

Circulating endothelial cells as a prognostic marker in thrombotic microangiopathy.

Thrombotic microangiopathy in haematopoietic stem cell transplantation: diagnosis and treatment.

Transplantation-associated thrombotic microangiopathy: effect of concomitant GVHD on efficacy of therapeutic plasma exchange.

Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation.

Successful early intervention for hyperacute transplant-associated thrombotic microangiopathy following pediatric hematopoietic stem cell transplantation.

P304

175-180

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1076029615599439

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

Vijaya Raj Bhatt

P577

2016-07-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26259912

http://www.w3.org/2001/XMLSchema#string